
Brady Corporation (BRC) reported a fifth consecutive year of record adjusted EPS, reaching $4.60 for fiscal 2025, with Q4 adjusted EPS up 5.9% to $1.26. This performance was supported by 2.4% organic sales growth in Q4 and 2.6% for the full year, complemented by 11.3% from acquisitions like Gravotech and Funai's Microfluidics, which expanded technical capabilities and product offerings in high-growth areas such as printers and consumables. While the Americas and Asia region saw strong organic growth, Europe and Australia faced macro headwinds, prompting cost reduction actions expected to improve future profitability. BRC significantly increased R&D investment and demonstrated commitment to shareholder returns with its 40th consecutive annual dividend increase and continued share buybacks. For fiscal 2026, the company forecasts adjusted EPS growth of 5.4-12% on low single-digit organic sales, anticipating that recent cost reductions and tariff mitigation efforts will largely offset an estimated $8-12 million in incremental tariff impact and ongoing economic challenges.
Brady Corporation (BRC) concluded fiscal 2025 with a fifth consecutive year of record adjusted earnings, posting a Q4 adjusted EPS of $1.26, a 5.9% year-over-year increase. Top-line growth was driven by acquisitions, which contributed 11.3% to sales, alongside 2.4% organic growth. A significant regional divergence was evident, with the Americas and Asia region delivering strong 4.3% organic growth, propelled by a nearly 12% expansion in the wire identification product line tied to data center and defense sector strength. Conversely, the Europe and Australia region contracted by 1.3% organically due to challenging macroeconomic conditions, prompting significant restructuring actions totaling $8.9 million in the quarter. These cost reductions are positioned to enhance future profitability, a key factor in the company's optimistic 2026 guidance. BRC is aggressively investing in its future, increasing R&D spending by 31% in Q4 to 5.8% of sales, fueled by strategic acquisitions like Gravotech and Funai's Microfluidics. This investment targets high-growth, high-margin areas like workplace automation and direct part marking. Despite a temporary dip in free cash flow due to inventory builds from facility consolidations and an anticipated $8 million to $12 million incremental tariff impact in FY2026, management projects adjusted EPS growth of 5.4% to 12%, signaling confidence that cost-saving initiatives and pricing actions will offset these headwinds. The company's commitment to shareholders was reaffirmed with its 40th consecutive annual dividend increase and $51 million in share repurchases, supported by a healthy net cash position of $74.6 million.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment